戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 e considered as we engineer a mouse model of Smith-Magenis syndrome.
2 dify disease progression in a mouse model of Smith-Magenis syndrome.
3 enic to the common deletion interval for the Smith-Magenis syndrome, a contiguous gene deletion syndr
4                                              Smith-Magenis syndrome and [dup(17)(p11.2p11.2)] are CGS
5 rocal genomic disorders; deletion associated Smith-Magenis syndrome and duplication associated Potock
6 approximately 240-kb interval located in the Smith-Magenis syndrome common deletion region in 17p11.2
7  point mutations in the RAI1 gene within the Smith-Magenis syndrome critical region have been reporte
8 urther research into additional genes in the Smith-Magenis syndrome critical region will help define
9     Cross sectional studies of patients with Smith-Magenis syndrome have found evidence for central a
10                                              Smith-Magenis syndrome is associated with a 3.7-Mb delet
11 der in a chimpanzee with features resembling Smith-Magenis syndrome mediated by a chimpanzee-specific
12 ndrome critical region have been reported in Smith-Magenis syndrome patients without detectable delet
13 lay in modifying features or severity of the Smith-Magenis syndrome phenotype.
14 p11.2, commonly deleted in patients with the Smith-Magenis syndrome (SMS) and duplicated in patients
15                                              Smith-Magenis syndrome (SMS) and Potocki-Lupski syndrome
16  hotspot was identified in patients with the Smith-Magenis syndrome (SMS) common deletion of approxim
17  an LCR sequence (middle SMS-REP) within the Smith-Magenis syndrome (SMS) common deletion.
18 h dup(17)(p11.2p11.2), the reciprocal of the Smith-Magenis syndrome (SMS) deletion, del(17)(p11.2p11.
19                                              Smith-Magenis syndrome (SMS) is a CGS associated with a
20                                              Smith-Magenis syndrome (SMS) is a clinically recognizabl
21                                              Smith-Magenis Syndrome (SMS) is a complex genomic disord
22                                              Smith-Magenis syndrome (SMS) is a genetic disorder cause
23                                              Smith-Magenis syndrome (SMS) is a genomic disorder cause
24                                              Smith-Magenis syndrome (SMS) is a mental retardation syn
25                                              Smith-Magenis syndrome (SMS) is a multiple congenital an
26                                              Smith-Magenis syndrome (SMS) is a multiple congenital an
27                                              Smith-Magenis syndrome (SMS) is a multiple congenital an
28                                              Smith-Magenis syndrome (SMS) is associated with an appro
29                                              Smith-Magenis syndrome (SMS) is caused by an approximate
30 e homologous recombination reciprocal of the Smith-Magenis syndrome (SMS) microdeletion (del(17)(p11.
31 y analyzing patients with antibody-deficient Smith-Magenis syndrome (SMS) who possess only 1 TNFRSF13
32 pped within the critical deletion region for Smith-Magenis syndrome (SMS), a disorder characterized b
33        Haploinsufficiency of RAI1 results in Smith-Magenis syndrome (SMS), a disorder characterized b
34 d-induced 1 (RAI1) haploinsufficiency causes Smith-Magenis syndrome (SMS), a genetic disorder with sy
35 0 genes identified in the critical region of Smith-Magenis syndrome (SMS), a genomic disorder with mu
36 ncy in retinoic acid induced 1 (RAI1) causes Smith-Magenis syndrome (SMS), a severe neurodevelopmenta
37 y with liability to pressure palsies (HNPP), Smith-Magenis syndrome (SMS), and mental retardation and
38                                              Smith-Magenis syndrome (SMS), caused by del(17)p11.2, re
39 B3 maps within the common deletion region of Smith-Magenis syndrome (SMS), del(17)(p11.2p11.2).
40                                           In Smith-Magenis syndrome (SMS), the dysregulation of both
41 ncy of Retinoic Acid Induced 1 (RAI1) causes Smith-Magenis syndrome (SMS), which is associated with d
42  one of the major clinical manifestations of Smith-Magenis syndrome (SMS).
43 eletion of 17p11.2, which is associated with Smith-Magenis syndrome (SMS).
44 tein, retinoic acid induced 1 (RAI1), causes Smith-Magenis syndrome (SMS).
45  in reduced expression of RAI1, which causes Smith-Magenis syndrome when haploinsufficient, providing